Fas apoptotic inhibitor molecule 2 mitigates metabolic dysfunction-associated fatty liver disease through autophagic CRTC2 degradation
Open Access
- 7 October 2025
- journal article
- research article
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 57 (10) , 2331-2343
Abstract
Lysosomal membrane proteins play fundamental roles in the lysosomal degradation of proteins and are attractive drug targets for metabolic dysfunction-associated fatty liver disease (MAFLD). Fas apoptotic inhibitory molecule 2 (FAIM2), a lysosomal membrane protein, has been recognized as an inhibitor of apoptosis in a variety of diseases. Here we reveal that FAIM2 is an inhibitor of fatty acid synthesis and suppresses MAFLD. FAIM2 protein expression is decreased in MAFLD. Moreover, FAIM2 is degraded by the E3 ubiquitin ligase NEDD4L through the catalysis of K48-linked ubiquitination. High-fat and high-cholesterol diet-induced hepatic steatosis, inflammation and fibrosis are aggravated in Faim2-knockout mice and alleviated in mice with AAV8-mediated FAIM2 overexpression. Furthermore, in hepatocytes, FAIM2 knockout increases the expression of genes related to fatty acid synthesis, while overexpressing FAIM2 exhibits the opposite effect. Mechanistically, FAIM2 directly interacts with CREB-regulated transcription coactivator 2 (CRTC2), a prominent regulator of lipid metabolism, and mediates its degradation through autophagy. Specifically, we find that the N terminus of FAIM2, which interacts with CRTC2 and LC3, is required for autophagic degradation of CRTC2. Collectively, our findings reveal that FAIM2 acts as a fatty acid synthesis inhibitor in MAFLD by promoting the autophagic degradation of CRTC2 and that FAIM2–CRTC2 may be a promising therapeutic target.Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- Lysosomal integral membrane protein-2: A new player in lysosome-related pathologyMolecular Genetics and Metabolism, 2014
- Modulation of Hippocampal Neuroplasticity by Fas/CD95 Regulatory Protein 2 (Faim2) in the Course of Bacterial MeningitisJournal of Neuropathology & Experimental Neurology, 2014
- cAMP-responsive Element-binding Protein (CREB)-regulated Transcription Coactivator 2 (CRTC2) Promotes Glucagon Clearance and Hepatic Amino Acid Catabolism to Regulate Glucose HomeostasisJournal of Biological Chemistry, 2013
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- Implication of Genetic Variants NearNEGR1,SEC16B,TMEM18,ETV5/DGKG,GNPDA2,LIN7C/BDNF,MTCH2,BCDIN3D/FAIM2,SH2B1,FTO,MC4R, andKCTD15with Obesity and Type 2 Diabetes in 7705 ChineseThe Journal of Clinical Endocrinology & Metabolism, 2010
- Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivityProceedings of the National Academy of Sciences, 2010
- Lifeguard/neuronal membrane protein 35 regulates Fas ligand‐mediated apoptosis in neurons via microdomain recruitmentJournal of Neurochemistry, 2007
- Lysosomal Membrane Proteomics and Biogenesis of LysosomesMolecular Neurobiology, 2005
- At the acidic edge: emerging functions for lysosomal membrane proteinsTrends in Cell Biology, 2003
- Neural Membrane Protein 35 (NMP35): A Novel Member of a Gene Family Which Is Highly Expressed in the Adult Nervous SystemMolecular and Cellular Neuroscience, 1998